OxSonics

OxSonics Therapeutics’ proprietary platform technology, SonoTran®enables the increased distribution of anti-cancer drugs in solid tunours by increasing their dose

61.7logo
logo
logo
logo
logo
logo
61.7
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logologo
Valuation
logo
$
Valuation
Funding
logo
$
$ 0.44 M
$ 17.51 M
Funding
$ 0.44 M
$ 17.51 M
Statistics
logo
NA
Action

OxSonics Therapeutics’ proprietary platform technology, SonoTran®enables the increased distribution of anti-cancer drugs in solid tunours by increasing their dose

0and0